Clinical Trials Browser

Completed × OTHER × Chromosome Aberrations × Clear all

NCT02403310 2022-10-03

A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML

Phase 1 Completed

Other hematologic neoplasm

Chromosome Aberrations, Leukemia, Leukemia, Myeloid, Acute

NCT05456048 2022-07-13

Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

Other hematologic neoplasm

Chromosome Aberrations, Recurrence, Leukemia, Myeloid, Acute